BPC
PFE icon

Bearing Point Capital’s Pfizer PFE Stock Holding History

Bearing Point Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$976K Buy
40,529
+13,700
+51% +$358K 0.13% 105
2026
Q1 		$753K Sell
26,829
-333
-1% -$8.87K 0.12% 108
2025
Q4 		$676K Sell
27,162
-18,937
-41% -$478K 0.11% 120
2025
Q3 		$1.17M Sell
46,099
-550
-1% -$13.6K 0.2% 85
2025
Q2 		$1.13M Sell
46,649
-5,491
-11% -$128K 0.21% 85
2025
Q1 		$1.32M Buy
52,140
+2,690
+5% +$70.4K 0.28% 78
2024
Q4 		$1.31M Buy
+49,450
New +$1.34M 0.27% 80

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bearing Point Capital's PFE Position: Q2 2026 in Review

Bearing Point Capital increased its Pfizer (PFE) stake by 51% in Q2 2026, buying an estimated $358K and bringing the position to 40,529 shares worth $976K. The position accounts for 0.13% of the portfolio, ranked #105.

Bearing Point Capital first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.32M in Q1 2025. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bearing Point Capital held 40,529 shares of Pfizer worth $976K as of Q2 2026.
  • Bearing Point Capital bought 13,700 Pfizer shares in Q2 2026, an estimated $358K.
  • Pfizer made up 0.13% of Bearing Point Capital's portfolio in Q2 2026, its #105 holding.
  • Bearing Point Capital first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Bearing Point Capital's Pfizer position peaked at $1.32M in Q1 2025.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bearing Point Capital's 13F filing for Q2 2026, filed 11 Aug 2026.